Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Haematology: Multiple Myeloma.

Cullis J.

Clin Med (Lond). 2019 Mar;19(2):188. doi: 10.7861/clinmedicine.19-2-188a. No abstract available.

2.

2015 UK software audit of hepatobiliary scintigraphy.

O'Shaughnessy ER, Murray A, Taylor JC, Barnfield M, Cullis J, Cade S, Kenny B, Carson KJ, Towey DJ, White D; Institute of Physics and Engineering in Medicine, Nuclear Medicine Software Quality Group.

Nucl Med Commun. 2019 Feb;40(2):136-144. doi: 10.1097/MNM.0000000000000948.

PMID:
30650067
3.

Does evidence-based medicine training improve doctors' knowledge, practice and patient outcomes? A systematic review of the evidence.

Simons MR, Zurynski Y, Cullis J, Morgan MK, Davidson AS.

Med Teach. 2019 May;41(5):532-538. doi: 10.1080/0142159X.2018.1503646. Epub 2018 Oct 17.

PMID:
30328793
4.

Transmission of diffuse large B-cell lymphoma by an allogeneic stem-cell transplant.

Araf S, Wang J, Ashton-Key M, Korfi K, Di Bella D, Rio-Machin A, Odabashian M, Foria V, Du MQ, Cucco F, Barrans S, Johnson P, Laird SR, Fisher AM, Cullis JO, Graham TA, Okosun J, Fitzgibbon J, Chiecchio L.

Haematologica. 2019 Apr;104(4):e174-e177. doi: 10.3324/haematol.2018.196907. Epub 2018 Jul 5. No abstract available.

5.

Pre-neoplastic pancreas cells enter a partially mesenchymal state following transient TGF-β exposure.

Handler J, Cullis J, Avanzi A, Vucic EA, Bar-Sagi D.

Oncogene. 2018 Aug;37(31):4334-4342. doi: 10.1038/s41388-018-0264-6. Epub 2018 May 1.

6.

Investigation and management of a raised serum ferritin.

Cullis JO, Fitzsimons EJ, Griffiths WJ, Tsochatzis E, Thomas DW; British Society for Haematology.

Br J Haematol. 2018 May;181(3):331-340. doi: 10.1111/bjh.15166. Epub 2018 Apr 19. Review.

PMID:
29672840
7.

Diagnosis and therapy of genetic haemochromatosis (review and 2017 update).

Fitzsimons EJ, Cullis JO, Thomas DW, Tsochatzis E, Griffiths WJH; British Society for Haematology.

Br J Haematol. 2018 May;181(3):293-303. doi: 10.1111/bjh.15164. Epub 2018 Apr 16. No abstract available.

PMID:
29663319
8.

Kras and Tumor Immunity: Friend or Foe?

Cullis J, Das S, Bar-Sagi D.

Cold Spring Harb Perspect Med. 2018 Sep 4;8(9). pii: a031849. doi: 10.1101/cshperspect.a031849. Review.

PMID:
29229670
9.

Not everything that can be counted counts…..

Cullis JO.

Br J Haematol. 2017 May;177(4):505-506. doi: 10.1111/bjh.14626. Epub 2017 May 3. No abstract available.

PMID:
28466987
10.

UK audit of quantitative thyroid uptake imaging.

Taylor JC, Murray AW, Hall DO, Barnfield MC, O'Shaugnessy ER, Carson KJ, Cullis J, Towey DJ, Kenny B.

Nucl Med Commun. 2017 Jul;38(7):608-616. doi: 10.1097/MNM.0000000000000681.

PMID:
28452796
11.

De novo Richter transformation.

Chiecchio L, Cullis JO.

Blood. 2017 Apr 27;129(17):2455. doi: 10.1182/blood-2017-02-766782. No abstract available.

12.

Interrogation of Functional Cell-Surface Markers Identifies CD151 Dependency in High-Grade Serous Ovarian Cancer.

Medrano M, Communal L, Brown KR, Iwanicki M, Normand J, Paterson J, Sircoulomb F, Krzyzanowski P, Novak M, Doodnauth SA, Saiz FS, Cullis J, Al-Awar R, Neel BG, McPherson J, Drapkin R, Ailles L, Mes-Massons AM, Rottapel R.

Cell Rep. 2017 Mar 7;18(10):2343-2358. doi: 10.1016/j.celrep.2017.02.028.

13.

Macropinocytosis of Nab-paclitaxel Drives Macrophage Activation in Pancreatic Cancer.

Cullis J, Siolas D, Avanzi A, Barui S, Maitra A, Bar-Sagi D.

Cancer Immunol Res. 2017 Mar;5(3):182-190. doi: 10.1158/2326-6066.CIR-16-0125. Epub 2017 Jan 20.

14.

A novel 33-Gene targeted resequencing panel provides accurate, clinical-grade diagnosis and improves patient management for rare inherited anaemias.

Roy NB, Wilson EA, Henderson S, Wray K, Babbs C, Okoli S, Atoyebi W, Mixon A, Cahill MR, Carey P, Cullis J, Curtin J, Dreau H, Ferguson DJ, Gibson B, Hall G, Mason J, Morgan M, Proven M, Qureshi A, Sanchez Garcia J, Sirachainan N, Teo J, Tedgård U, Higgs D, Roberts D, Roberts I, Schuh A.

Br J Haematol. 2016 Oct;175(2):318-330. doi: 10.1111/bjh.14221. Epub 2016 Jul 19.

15.

Quantification of 18FDG in the Normal Colon-A First Step in Investigating Whether Its Presence Is a Marker of a Physiological Process.

Bardhan KD, Cullis J, Williams NR, Arasaradnam RP, Wilson AJ.

PLoS One. 2016 Jan 28;11(1):e0147838. doi: 10.1371/journal.pone.0147838. eCollection 2016.

16.

Draft Genome Sequences of Ralstonia solanacearum Race 3 Biovar 2 Strains with Different Temperature Adaptations.

Yuan KX, Cullis J, Lévesque CA, Tambong J, Chen W, Lewis CT, De Boer SH, Li XS.

Genome Announc. 2015 Aug 13;3(4). pii: e00815-15. doi: 10.1128/genomeA.00815-15.

17.

Interpreting raised serum ferritin levels.

Koperdanova M, Cullis JO.

BMJ. 2015 Aug 3;351:h3692. doi: 10.1136/bmj.h3692. No abstract available.

PMID:
26239322
18.

Draft Genome Sequences for Canadian Isolates of Pectobacterium carotovorum subsp. brasiliense with Weak Virulence on Potato.

Li XS, Yuan KX, Cullis J, Lévesque CA, Chen W, Lewis CT, De Boer SH.

Genome Announc. 2015 Apr 9;3(2). pii: e00240-15. doi: 10.1128/genomeA.00240-15.

19.

The RhoGEF GEF-H1 is required for oncogenic RAS signaling via KSR-1.

Cullis J, Meiri D, Sandi MJ, Radulovich N, Kent OA, Medrano M, Mokady D, Normand J, Larose J, Marcotte R, Marshall CB, Ikura M, Ketela T, Moffat J, Neel BG, Gingras AC, Tsao MS, Rottapel R.

Cancer Cell. 2014 Feb 10;25(2):181-95. doi: 10.1016/j.ccr.2014.01.025.

20.

The impact of phenotypic and genetic heterogeneity on results of genome wide association studies of complex diseases.

Manchia M, Cullis J, Turecki G, Rouleau GA, Uher R, Alda M.

PLoS One. 2013 Oct 11;8(10):e76295. doi: 10.1371/journal.pone.0076295. eCollection 2013.

21.

Application of a novel tool for diagnosing bile acid diarrhoea.

Covington JA, Westenbrink EW, Ouaret N, Harbord R, Bailey C, O'Connell N, Cullis J, Williams N, Nwokolo CU, Bardhan KD, Arasaradnam RP.

Sensors (Basel). 2013 Sep 6;13(9):11899-912. doi: 10.3390/s130911899.

22.

Anaemia of chronic disease.

Cullis J.

Clin Med (Lond). 2013 Apr;13(2):193-6. doi: 10.7861/clinmedicine.13-2-193. Review. No abstract available.

23.

The treatment of recurrent epistaxis due to hereditary haemorrhagic telangiectasia with intranasal bevacizumab.

Alderman C, Corlett J, Cullis J.

Br J Haematol. 2013 Aug;162(4):547-8. doi: 10.1111/bjh.12377. Epub 2013 May 14. No abstract available.

PMID:
23672440
24.

18F-Fluorodeoxyglucose: the Trojan horse of PET/CT.

Arasaradnam RP, Penny R, Cullis J, Williams N, Wilson A, Bardhan KD.

Nucl Med Commun. 2012 Dec;33(12):1312. doi: 10.1097/MNM.0b013e328359d3a6. No abstract available.

PMID:
23014244
25.

Guidelines on obtaining consent for systemic anti-cancer therapy in adults.

Treleaven J, Gadd E, Cullis J, Favre J, McLeod A, Meller S, Milligan D, Neilson R, Quinn B, Webb A, Wimperis J.

Hematology. 2012 Sep;17(5):249-54. doi: 10.1179/1607845412Y.0000000022. Review.

PMID:
22971529
26.

Brain structural signature of familial predisposition for bipolar disorder: replicable evidence for involvement of the right inferior frontal gyrus.

Hajek T, Cullis J, Novak T, Kopecek M, Blagdon R, Propper L, Stopkova P, Duffy A, Hoschl C, Uher R, Paus T, Young LT, Alda M.

Biol Psychiatry. 2013 Jan 15;73(2):144-52. doi: 10.1016/j.biopsych.2012.06.015. Epub 2012 Jul 20.

27.

Hippocampal volumes in bipolar disorders: opposing effects of illness burden and lithium treatment.

Hajek T, Cullis J, Novak T, Kopecek M, Höschl C, Blagdon R, O'Donovan C, Bauer M, Young LT, Macqueen G, Alda M.

Bipolar Disord. 2012 May;14(3):261-70. doi: 10.1111/j.1399-5618.2012.01013.x.

28.

Bile acid malabsorption and SeHCAT: the 'Cinderella' will be going to the Nuclear Medicine Ball!

Arasaradnam RP, Cullis J, Nwokolo C, Bardhan K, Williams N.

Nucl Med Commun. 2012 May;33(5):449-51. doi: 10.1097/MNM.0b013e328351d516. No abstract available.

PMID:
22395031
29.

Large positive effect of lithium on prefrontal cortex N-acetylaspartate in patients with bipolar disorder: 2-centre study.

Hajek T, Bauer M, Pfennig A, Cullis J, Ploch J, O'Donovan C, Bohner G, Klingebiel R, Young LT, Macqueen GM, Alda M.

J Psychiatry Neurosci. 2012 May;37(3):185-92. doi: 10.1503/jpn.110097.

30.

Diagnosis and management of anaemia of chronic disease: current status.

Cullis JO.

Br J Haematol. 2011 Aug;154(3):289-300. doi: 10.1111/j.1365-2141.2011.08741.x. Epub 2011 May 25. Review.

PMID:
21615381
31.

How to get the most from the medical literature: keeping up to date in nephrology.

Cullis J, Webster AC.

Nephrology (Carlton). 2010 Apr;15(3):269-76. doi: 10.1111/j.1440-1797.2010.01282.x.

PMID:
20470293
32.

Facilities for the treatment of adults with haematological malignancies--'Levels of Care': BCSH Haemato-Oncology Task Force 2009.

Matthey F, Parker A, Rule SA, Wimperis JZ, Ardeshna KM, Bird JM, Cullis J, Lyttelton MP, McMillan A, Jackson GH.

Hematology. 2010 Apr;15(2):63-9. doi: 10.1179/102453309X12583347113492. No abstract available.

PMID:
20423565
33.

Service users' views of eating disorder services: an international comparison.

Escobar-Koch T, Banker JD, Crow S, Cullis J, Ringwood S, Smith G, van Furth E, Westin K, Schmidt U.

Int J Eat Disord. 2010 Sep;43(6):549-59. doi: 10.1002/eat.20741.

PMID:
19718664
34.

Clonal diversity in the myeloproliferative neoplasms: independent origins of genetically distinct clones.

Beer PA, Jones AV, Bench AJ, Goday-Fernandez A, Boyd EM, Vaghela KJ, Erber WN, Odeh B, Wright C, McMullin MF, Cullis J, Huntly BJ, Harrison CN, Cross NC, Green AR.

Br J Haematol. 2009 Mar;144(6):904-8. doi: 10.1111/j.1365-2141.2008.07560.x. Epub 2009 Jan 16.

PMID:
19170680
35.

Cost-effectiveness of rituximab in refractory cold agglutinin disease.

Panwar U, Mathews C, Cullis JO.

Int J Lab Hematol. 2008 Aug;30(4):331-3. doi: 10.1111/j.1751-553X.2007.00958.x.

PMID:
18665831
36.

Guidelines on the management of acute myeloid leukaemia in adults.

British Committee for Standards in Haematology, Milligan DW, Grimwade D, Cullis JO, Bond L, Swirsky D, Craddock C, Kell J, Homewood J, Campbell K, McGinley S, Wheatley K, Jackson G.

Br J Haematol. 2006 Nov;135(4):450-74. Epub 2006 Oct 10. Review. No abstract available.

PMID:
17054678
37.

Blindness due to angioid streaks in congenital dyserythropoietic anaemia type I.

Roberts E, Madhusudhana KC, Newsom R, Cullis JO.

Br J Haematol. 2006 Jun;133(5):456. No abstract available.

PMID:
16681633
38.

Obtaining consent for chemotherapy.

Treleaven J, Cullis JO, Maynard R, Bishop E, Ainsworth-Smith I, Roques A, Webb A, Favre J, Milligan D; British Committee for Standards in Haematology.

Br J Haematol. 2006 Mar;132(5):552-9. No abstract available.

PMID:
16445827
39.

An audit of post-splenectomy prophylaxis--are we following the guidelines?

Ramachandra J, Bond A, Ranaboldo C, Cullis J.

Ann R Coll Surg Engl. 2003 Jul;85(4):252-5.

40.

Patients with essential thrombocythemia do not express BCR-ABL transcripts.

Hackwell S, Ross F, Cullis JO.

Blood. 1999 Apr 1;93(7):2420-1. No abstract available.

41.

Acute leukaemia in Jehovah's Witnesses.

Cullis JO, Duncombe AS, Dudley JM, Lumley HS, Apperley JF, Smith AG.

Br J Haematol. 1998 Mar;100(4):664-8.

PMID:
9531331
42.

Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of poor-risk myelodysplastic syndromes and acute myeloid leukaemia.

Parker JE, Pagliuca A, Mijovic A, Cullis JO, Czepulkowski B, Rassam SM, Samaratunga IR, Grace R, Gover PA, Mufti GJ.

Br J Haematol. 1997 Dec;99(4):939-44.

PMID:
9432047
43.

Decision making in quasi-markets: a pedagogic analysis.

Jones PR, Cullis JG.

J Health Econ. 1996 Apr;15(2):187-208.

PMID:
10159109
45.

Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse.

van Rhee F, Lin F, Cullis JO, Spencer A, Cross NC, Chase A, Garicochea B, Bungey J, Barrett J, Goldman JM.

Blood. 1994 Jun 1;83(11):3377-83.

46.
47.

Immunological characterization of the tumor-specific bcr/abl junction of Philadelphia chromosome positive chronic myeloid leukemia.

Barrett J, Guimaraes A, Cullis J, Goldman JM.

Stem Cells. 1993 Oct;11 Suppl 3:104-8.

PMID:
8298471
48.

Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years.

Marks DI, Cullis JO, Ward KN, Lacey S, Syzdlo R, Hughes TP, Schwarer AP, Lutz E, Barrett AJ, Hows JM, Batchelor JR, Goldman JM.

Ann Intern Med. 1993 Aug 1;119(3):207-14.

PMID:
8391772
49.
50.

Matched unrelated donor bone marrow transplantation for chronic myeloid leukaemia in chronic phase: comparison of ex vivo and in vivo T-cell depletion.

Cullis JO, Szydlo RM, Cross NC, Marks DI, Schwarer AP, Hughes TP, Mackinnon S, Hale G, Waldmann H, Hows JM, et al.

Bone Marrow Transplant. 1993;11 Suppl 1:107-11.

PMID:
8448531

Supplemental Content

Loading ...
Support Center